Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
株式のランク #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
株価
$0.0009
最終同期: 2025-05-27
時価総額
$1.15K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Arch Therapeutics, Inc. (ARTH)

カテゴリー

Arch Therapeutics, Inc.(ARTH)のP/S比率
August 2026 時点のP/S比率 TTM: 0.01
Arch Therapeutics, Inc. の最新の財務報告および株価によると、現在のP/S比率(TTM)は 0.01 です。2022 年末時点でのP/S比率は 294.30 でした。
Arch Therapeutics, Inc. の P/S 比率の履歴(2011 ~ 2026)
各年末時点のP/S比率
P/S比率 変化
2026 (TTM) 0.01 -99.99%
2023 52.78 -82.07%
2022 294.30 -88.10%
2021 2.47K 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
同業他社のP/S比率
企業 P/S比率 P/S比率の差
9.88 167,371.19%
US
10.30 174,527.12%
NL
- -
CH
4.98 84,294.92%
BE
- -
KR